katzung.pdf

(27532 KB) Pobierz
a LANGE medical book
Pharmacology
Examination
& Board Review
Eleventh Edition
Katzung & Trevor’s
Anthony J. Trevor, PhD
Professor Emeritus of Pharmacology and Toxicology
Department of Cellular & Molecular Pharmacology
University of California, San Francisco
Bertram G. Katzung, MD, PhD
Professor Emeritus of Pharmacology
Department of Cellular & Molecular Pharmacology
University of California, San Francisco
Marieke Kruidering-Hall, PhD
Associate Professor & Academy Chair of Pharmacology Education
Department of Cellular & Molecular Pharmacology
University of California, San Francisco
New York Chicago San Francisco Athens London Madrid Mexico City
Milan New Delhi Singapore Sydney Toronto
Copyright © 2015, 2013, 2010, 2008, 2005, 2002 by McGraw-Hill Education. All rights reserved. Except as permitted under the United States Copyright Act of 1976,
no part of this publication may be reproduced or distributed in any form or by any means, or stored in a database or retrieval system, without the prior written permission
of the publisher, with the exception that the program listings may be entered, stored, and executed in a computer system, but they may not be reproduced for publication.
ISBN: 978-0-07-182639-6
MHID: 0-07-182639-4
The material in this eBook also appears in the print version of this title: ISBN: 978-0-07-182635-8,
MHID: 0-07-182635-1.
eBook conversion by codeMantra
Version 1.0
All trademarks are trademarks of their respective owners. Rather than put a trademark symbol after every occurrence of a trademarked name, we use names in an
editorial fashion only, and to the benefit of the trademark owner, with no intention of infringement of the trademark. Where such designations appear in this book, they
have been printed with initial caps.
McGraw-Hill Education eBooks are available at special quantity discounts to use as premiums and sales promotions or for use in corporate training programs. To contact
a representative, please visit the Contact Us page at www.mhprofessional.com.
Previous editions copyright © 1998, 1995, 1993, 1990 by Appleton & Lange.
Notice
Medicine is an ever-changing science. As new research and clinical experience broaden our knowledge, changes in treatment and drug therapy are required. The authors
and the publisher of this work have checked with sources believed to be reliable in their efforts to provide information that is complete and generally in accord with the
standards accepted at the time of publication. However, in view of the possibility of human error or changes in medical sciences, neither the authors nor the publisher
nor any other party who has been involved in the preparation or publication of this work warrants that the information contained herein is in every respect accurate or
complete, and they disclaim all responsibility for any errors or omissions or for the results obtained from use of the information contained in this work. Readers are
encouraged to confirm the information contained herein with other sources. For example and in particular, readers are advised to check the product information sheet
included in the package of each drug they plan to administer to be certain that the information contained in this work is accurate and that changes have not been made in
the recommended dose or in the contraindications for administration. This recommendation is of particular importance in connection with new or infrequently used drugs.
TERMS OF USE
This is a copyrighted work and McGraw-Hill Education and its licensors reserve all rights in and to the work. Use of this work is subject to these terms. Except as
permitted under the Copyright Act of 1976 and the right to store and retrieve one copy of the work, you may not decompile, disassemble, reverse engineer, reproduce,
modify, create derivative works based upon, transmit, distribute, disseminate, sell, publish or sublicense the work or any part of it without McGraw-Hill Education’s
prior consent. You may use the work for your own noncommercial and personal use; any other use of the work is strictly prohibited. Your right to use the work may be
terminated if you fail to comply with these terms.
THE WORK IS PROVIDED “AS IS.” McGRAW-HILL EDUCATION AND ITS LICENSORS MAKE NO GUARANTEES OR WARRANTIES AS TO THE
ACCURACY, ADEQUACY OR COMPLETENESS OF OR RESULTS TO BE OBTAINED FROM USING THE WORK, INCLUDING ANY INFORMATION
THAT CAN BE ACCESSED THROUGH THE WORK VIA HYPERLINK OR OTHERWISE, AND EXPRESSLY DISCLAIM ANY WARRANTY, EXPRESS OR
IMPLIED, INCLUDING BUT NOT LIMITED TO IMPLIED WARRANTIES OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. McGraw-Hill
Education and its licensors do not warrant or guarantee that the functions contained in the work will meet your requirements or that its operation will be uninterrupted or
error free. Neither McGraw-Hill Education nor its licensors shall be liable to you or anyone else for any inaccuracy, error or omission, regardless of cause, in the work or
for any damages resulting therefrom. McGraw-Hill Education has no responsibility for the content of any information accessed through the work. Under no circumstances
shall McGraw-Hill Education and/or its licensors be liable for any indirect, incidental, special, punitive, consequential or similar damages that result from the use of or
inability to use the work, even if any of them has been advised of the possibility of such damages. This limitation of liability shall apply to any claim or cause whatsoever
whether such claim or cause arises in contract, tort or otherwise.
Contents
Preface
v
part
I
1
part
IV
BASIC PRINCIPLES
1.
Introduction 1
DRUGS WITH IMPORTANT ACTIONS
ON SMOOTH MUSCLE 143
16.
Histamine, Serotonin, & the Ergot
Alkaloids 143
17.
Vasoactive Peptides
152
2.
Pharmacodynamics 16
3.
Pharmacokinetics 26
4.
Drug Metabolism 35
5.
Pharmacogenomics 41
part
18.
Prostaglandins & Other Eicosanoids 158
19.
Nitric Oxide, Donors, & Inhibitors 165
20.
Drugs Used in Asthma & Chronic
Obstructive Pulmonary Disease 169
II
47
AUTONOMIC DRUGS
part
V
6.
Introduction to Autonomic Pharmacology 47
7.
Cholinoceptor-Activating
& Cholinesterase-Inhibiting Drugs 60
8.
Cholinoceptor Blockers & Cholinesterase
Regenerators 69
9.
Sympathomimetics 76
10.
Adrenoceptor Blockers 85
part
DRUGS THAT ACT IN THE CENTRAL
NERVOUS SYSTEM 179
21.
Introduction to CNS Pharmacology 179
22.
Sedative-Hypnotic Drugs 186
23.
Alcohols
194
24.
Antiseizure Drugs 201
25.
General Anesthetics
208
III
93
CARDIOVASCULAR DRUGS
26.
Local Anesthetics
216
11.
Drugs Used in Hypertension 93
12.
Drugs Used in the Treatment of Angina
Pectoris 103
13.
Drugs Used in Heart Failure 112
14.
Antiarrhythmic Drugs 121
15.
Diuretics & Other Drugs That Act on the
Kidney 132
27.
Skeletal Muscle Relaxants 221
28.
Drugs Used in Parkinsonism & Other
Movement Disorders 229
29.
Antipsychotic Agents & Lithium 236
30.
Antidepressants
244
31.
Opioid Analgesics & Antagonists 252
32.
Drugs of Abuse 260
iii
iv
CONTENTS
part
VI
47.
Antimycobacterial Drugs
48.
Antifungal Agents
395
389
DRUGS WITH IMPORTANT ACTIONS
ON BLOOD, INFLAMMATION,
& GOUT 267
33.
Agents Used in Cytopenias; Hematopoietic
Growth Factors 267
34.
Drugs Used in Coagulation Disorders 276
35.
Agents Used in Dyslipidemia 288
36.
NSAIDs, Acetaminophen, & Drugs Used in
Rheumatoid Arthritis & Gout 296
part
49.
Antiviral Chemotherapy & Prophylaxis 402
50.
Miscellaneous Antimicrobial Agents
& Urinary Antiseptics 414
51.
Clinical Use of Antimicrobials 420
52.
Antiprotozoal Drugs
426
53.
Antihelminthic Drugs 434
54.
Cancer Chemotherapy
55.
Immunopharmacology
part
440
452
VII
307
ENDOCRINE DRUGS
IX
463
TOXICOLOGY
37.
Hypothalamic & Pituitary Hormones 307
38.
Thyroid & Antithyroid Drugs 316
39.
Corticosteroids & Antagonists 322
40.
Gonadal Hormones & Inhibitors 329
41.
Pancreatic Hormones, Antidiabetic Agents,
& Glucagon 340
42.
Drugs That Affect Bone Mineral
Homeostasis 349
part
56.
Environmental & Occupational
Toxicology 463
57.
Heavy Metals
469
58.
Management of the Poisoned Patient 475
part
X
483
SPECIAL TOPICS
59.
Drugs Used in Gastrointestinal
Disorders 483
VIII
359
CHEMOTHERAPEUTIC DRUGS
60.
Dietary Supplements & Herbal
Medications 492
61.
Drug Interactions
497
43.
Beta-Lactam Antibiotics & Other Cell Wall
Synthesis Inhibitors 360
44.
Chloramphenicol, Tetracyclines,
Macrolides, Clindamycin, Streptogramins,
& Linezolid 369
45.
Aminoglycosides
377
Appendix I.
Strategies for Improving Test
Performance 503
Appendix II.
Key Words for Key Drugs 506
Appendix III.
Examination 1
Appendix IV.
Examination 2
Index
518
534
46.
Sulfonamides, Trimethoprim, &
Fluoroquinolones 382
549
Zgłoś jeśli naruszono regulamin